ACUTE ISCHEMIC STROKE

This study tests an investigational drug called HRS-7450 in 208 people who have had an acute ischemic stroke within the past 4.5 to 24 hours. Participants receive either a low, intermediate, or high dose of the drug or a placebo. The goal is to see if the drug helps improve recov…

This study tests whether giving a fructose (a type of sugar) injection soon after a stroke, along with standard clot-busting treatment, can improve brain recovery. About 46 adults who have a stroke within the last 4.5 hours will be randomly assigned to receive either fructose plu…

This study tests whether adding an interleukin-6 receptor inhibitor (a drug that reduces inflammation) to standard emergency stroke treatment helps people recover better after a severe stroke caused by a large blood clot in the front part of the brain. About 692 adults who are el…

This large Phase 3 study tests whether milvexian, an experimental oral blood thinner, can prevent another stroke in people who recently had a mild stroke or a high-risk mini-stroke (TIA). Over 12,500 participants are randomly assigned to receive either milvexian or a placebo, alo…

This phase 2 trial tests whether giving the clot-busting drug tenecteplase directly into the brain artery after standard clot removal is safe and feasible for people with severe stroke. About 40 participants who had a large artery blockage will receive either the drug or a saltwa…

This study tests whether infusing a cold magnesium sulfate solution directly into the brain during emergency clot removal can improve outcomes for people with acute ischemic stroke. About 42 adults aged 18-80 with severe strokes will be randomly assigned to receive either standar…

This study tests whether a structured exercise program done at home can improve walking ability and overall recovery in people who recently had a stroke. About 208 adults who had a stroke within the past two weeks will be assigned to either the home exercise program or usual care…

This study tests a new biologic drug called redasemtide in 680 adults who have had an acute ischemic stroke. Participants receive either the drug or a placebo within 25 hours of their stroke. The goal is to see if redasemtide improves recovery and reduces disability at 90 days. T…

This study looks at whether a procedure called endovascular treatment (EVT) can help people who have had a mild stroke caused by a blocked large artery in the brain. About 300 participants will either receive EVT plus standard medical care or standard care alone. The goal is to s…

This study tested a one-time intravenous infusion of donor stem cells in adults aged 18 to 80 who had a recent (within 9 days) ischemic stroke. The goal was to help the brain heal and improve recovery. While promising, this approach is not a cure and patients still need standard …

This study planned to test whether adding the antibiotic minocycline to standard stroke treatment could improve recovery in people who had a severe stroke. It was designed as a small, early-phase trial with about 40 participants, but it was withdrawn before enrolling anyone. Beca…

This early study tests a new stent, called CGuard Prime, in 15 adults having a stroke from a blocked carotid artery. The goal is to see if placing the stent is safe and helps patients recover better by 90 days. Researchers will also check for complications like bleeding or new st…

This study tests whether carefully managing blood pressure during a clot-removal procedure for stroke can improve patient recovery. About 550 people having emergency clot retrieval will have their systolic blood pressure kept within a specific target range. Researchers will then …

This early-phase trial tests whether stem cells from donated umbilical cords are safe for people who recently had a stroke. Ten participants receive the cells through a vein or directly into the brain's arteries. Researchers monitor for side effects and look for any signs of impr…

This study tests whether giving the steroid methylprednisolone along with standard clot-removal treatment can lower the risk of death or severe disability in people who have had a major stroke. About 928 adults with a large blockage in a main brain artery will receive either the …

This trial was designed to test a device called the CEREGLIDE 92 catheter, which aims to remove large blood clots from the brain in people having a severe stroke. The study planned to enroll patients with acute ischemic stroke and high disability scores. However, the trial was wi…

This study tests whether a water-resistant, wireless ECG patch worn for 7 days can detect more cases of hidden atrial fibrillation (a heart rhythm problem that raises stroke risk) than the usual 24-hour Holter monitor. Researchers will enroll 320 adults who recently had a stroke …

This study tests whether following the MIND diet for 2 to 3 years can slow cognitive decline and reduce dementia risk in people aged 55 and older who have had an ischemic stroke. The MIND diet combines elements of the Mediterranean and DASH diets, with extra emphasis on leafy gre…

This study looks at whether MRI or CT should be the first scan for people with suspected acute ischemic stroke. Researchers will track how often doctors follow the assigned scan type and compare outcomes. The goal is to see if a larger study comparing these imaging methods is pos…

This study looks at 20 adults who had a stroke within the past week. Each person will get both a CT scan and a PET scan of the brain to see which method better shows blood flow and metabolism. The goal is to find the best way to image stroke damage, not to test a new treatment.

This study follows 1,000 stroke survivors and their caregivers to understand how social factors and discrimination affect recovery. Researchers will survey participants over time to measure outcomes like quality of life and caregiver strain. The goal is to identify why some group…

This study looks at whether a blood test can help doctors figure out when a stroke began. This is important because some people wake up with stroke symptoms and don't know the exact start time, which can prevent them from getting clot-busting drugs. Researchers will take blood fr…

This study looks at how certain immune cells (neutrophils) behave in people having a severe stroke. Researchers want to find the best time and target for treatments that block these cells. 440 adults having emergency stroke treatment will give blood samples and have their recover…

This study looks at 250 stroke patients to understand why some arrive late at the hospital. Researchers use a questionnaire, mapping tools, and brain scans to find social, transport, and knowledge barriers. A machine learning model will try to predict who is at risk for delay, wi…